Argenica Therapeutics Limited (ASX: $AGN) has requested a trading halt for its securities pending an announcement regarding a capital raising. The halt is expected to remain in place until the earlier of the commencement of normal trading on Friday, 12 April 2024, or when the announcement concerning the capital raising is released.
The Company requests the trading halt to ensure that the market is properly informed about the upcoming capital raising announcement. We believe this is a necessary step to maintain transparency and provide equal opportunity for all investors to assess the information when it is released.
Argenica Therapeutics (ASX: $AGN) has requested a trading halt in preparation for an upcoming announcement regarding a capital raising. The company aims to ensure that all investors have equal access to the information once it is released, emphasizing transparency and fair market practices. The halt is expected to be lifted upon the release of the announcement, allowing normal trading to resume. This move reflects the company's commitment to maintaining open communication with the market and providing timely updates on significant developments.